Health impact of peptic ulcer in the United States

American Journal of Gastroenterology

Volumn 92, Issue 4, 1997, Pages 614-620

  Sonnenberg, Amnon ^a   Everhart, James E ^b  

^a VA Medical Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PEPTIC ULCER; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CONFIDENCE INTERVALS; COST OF ILLNESS; COSTS AND COST ANALYSIS; FEMALE; HEALTH STATUS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PEPTIC ULCER; PREVALENCE; QUESTIONNAIRES; RANDOM ALLOCATION; SEX DISTRIBUTION; SICKNESS IMPACT PROFILE; UNITED STATES;

EID: 0030891527     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Sonnenberg A, Everhart JE. The prevalence of self-reported peptic ulcer in the United States. Am J Public Health 1996;86:200-5.
2. Sandler RS, Everhart J, Fenster F, et al. A primer on outcomes research for the gastroenterologist: Report of the American Gastroenterological Association task force on outcomes research. Gastroenterology 1995; 109:302-6.
3. Shah BV. SESUDAAN: Standard errors program for computing of standardized rates from sample survey data. Research Triangle Park, NC: Research Triangle Institute, 1981.
4. Shah BV, Foison RE, Harrell FE, et al. RTILOGIT: Survey data analysis software for logistic regression. Research Triangle Park, NC: Research Triangle Institute, 1981.
5. SAS Institute. SAS/STAT User's guide, version 6, 4th ed, vol 2. Cary NC: SAS Institute, 1992.
6. US. Bureau of the Census. Statistical abstract of the United States: 1995, 115th ed. Washington, DC: US Government Printing Office, 1995:Tables 179, 187, 675, 1315.
7. Johnson B, Read P. Patients' comments on successful Helicobacter pylori eradication treatment. Am J Gastroenterol 1994;89:1374 (abstract).
8. Phull PS, Ryder SD, Halliday D, et al. The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease: A community-based study. Postgrad Med J 1995;71:413-8.
9. Powell KU, Bell GD, Bolton GH, et al. Helicobacter pylori eradication in patients with peptic ulcer disease: Clinical consequences and financial implications. Q J Med 1994;87:283-90.
10. Sonnenberg A. Concordant occurrence of gastric and hypertensive diseases. Gastroenterology 1988;95:42-8.
11. Sonnenberg A, Wasserman IH. Associations of peptic ulcer and gastric cancer with other diseases. Am J Public Health 1995;85:1252-5.
12. Sonnenberg A. Factors which influence the incidence and the course of peptic ulcer. Scand J Gastroenterol 1988;23(suppl 155):119-40.
13. Anda RF, Williamson DF, Escobedo LG, et al. Smoking and the risk of peptic ulcer disease among women in the United States. Arch Intern Med 1992;150:1437-41.
14. Anda RF, Williamson DF, Escobedo LG, et al. Self-perceived stress and the risk of peptic ulcer disease: A longitudinal study of US adults. Arch Intern Med 1992;152:829-33.
15. Kurata JH. Epidemiology: Peptic ulcer risk factors. Sem Gastrointest Dis 1993;4:2-12.
16. Sonnenberg A. Peptic ulcer. In: Everhart JE, ed. Digestive diseases in the United States: Epidemiology and impact. US Department of Health and Human Services, NIH publication no. 94-1447. Washington, DC: US Government Printing Office, 1994:357-408.
17. Schütze K, Hentschel E, Dragosics B, et al. Helicobacter pylori reinfection with identical organisms: Transmission by the patients' spouses. Gut 36:831-83.
18. Labenz J, Tillenburg B, Peitz U, et al. Incidence of reflux esophagitis after cure of Helicobacter pylori infection in duodenal ulcer patients. Gastroenterology 1995;108:A140.
19. Sonnenberg A. Cost-impact of clarithromycin plus omeprazole compared to traditional therapies for treatment of H. pylori-associated duodenal ulcers. Gut 1996;39(suppl 3):A37.
20. Sonnenberg A, The Gastrointestinal Utilization Trial Study Group. Comparative cost-effectiveness of three ulcer therapies. Gastroenterology (in press).
21. Korman MG. Quality of life in duodenal ulcer. Scand J Gastroenterol 1993;28(suppl 199):28-31.
22. Hallerbäck B. Assessment of quality of life among patients with suspected duodenal ulcer. Scand J Gastroenterol 1993;28(suppl 199): 32-3.
23. Glise H. Quality of life assessments in patients with peptic ulcer during treatment and follow-up. Scand J Gastroenterol 1993;28(suppl 199): 34-5.
24. Glise H, Hallerbäck B, Johansson B. Quality of life assessments in the evaluation of gastroesophageal reflux and peptic ulcer disease before, during and after treatment. Scand J Gastroenterol 1995;28(suppl 208): 133-5.
25. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
26. IMS America, Ltd. National Disease and Therapeutic Index. Plymouth Meeting, Pennsylvania, 1990.
27. Sonnenberg A, Townsend WF. Costs of duodenal ulcer therapy with antibiotics. Arch Intern Med 1995;155:922-8.
28. Imperiale TF, Speroff T, Cebul RD, et al. A cost analysis of alternative treatments for duodenal ulcer. Ann Intern Med 1995;123:665-72.
29. Vakil N, Fennerty MB. Cost effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. Am J Gastroenterol 1966;91:239-45.